tirzepatide portland for Insulin Resistance in Portland, Oregon Weight Loss Wellness Program |

In late 2023, researchers published the results of the Phase III SELECT trial that investigated the use of semaglutide in patients with overweight and a previous history of cardiovascular disease but no diagnosis of diabetes

Ultimately, protecting heart health during weight loss is about balance achieving a meaningful calorie deficit without compromising the nutritional foundations the heart depends upon

Perimenopause and Menopause are often associated with weight gain, increased abdominal body fat, irregular periods, mood swings, low libido, and thinning hair

For menopausal women specifically, response rates are similar to younger populations, but the *quality* of weight loss is often bettermore fat, less lean musclebecause GLP-1 preserves metabolic tissue